← Back to Search

Interactive Virtual Workday Training for Autism

N/A
Waitlist Available
Led By Matthew J Smith, PhD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18-26 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and posttest (approximately 6 weeks after baseline)
Awards & highlights

Study Summary

This trial proposes to develop and test the effectiveness of a computerized training tool to help nearly 50,000 youth with autism get and keep jobs. It will help them prepare for effective workplace communication, apply social cognitive strategies, and practice simulated conversations.

Who is the study for?
This trial is for young adults aged 18-26 with Autism Spectrum Disorder (ASD) who can read at a 4th-grade level or higher. Participants must either have an ASD diagnosis confirmed by parent report on the Social Responsivity Scale or have an ASD record with MCTI.Check my eligibility
What is being tested?
The 'Work Chat: An Interactive Virtual Workday' tool is being tested to improve workplace communication skills in individuals with ASD. It includes e-learning, simulated conversations using PeopleSim technology, and a virtual workday environment where early actions affect later interactions.See study design
What are the potential side effects?
Since this intervention involves educational and simulation-based training tools rather than medical treatments, traditional physical side effects are not applicable. However, participants may experience frustration or anxiety during challenging simulations.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 26 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and posttest (approximately 6 weeks after baseline)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and posttest (approximately 6 weeks after baseline) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Emotion Recognition Ability - MiniPONs
Change in Emotion Regulation - Emotion Dysregulation Inventory Short Form (Reactivity Index Short Form)
Change in Managing Emotions
+2 more
Secondary outcome measures
Change in Anxiety
Greater Gains/Change in Workplace Functioning - Workplace Behavior Inventory (WBI)
Other outcome measures
Change in Social Competence/Applied Social Ability

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Standard Transition Services + Work ChatExperimental Treatment1 Intervention
This arm will receive services as usual plus the Work Chat intervention over a series of a few weeks. We estimate approximately 15-18 hours of training will occur.
Group II: Standard Transition ServicesActive Control1 Intervention
This arm will receive services as usual.

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor
1,810 Previous Clinical Trials
6,384,805 Total Patients Enrolled
9 Trials studying Autism Spectrum Disorder
1,362 Patients Enrolled for Autism Spectrum Disorder
SIMmersion, LLCIndustry Sponsor
7 Previous Clinical Trials
734 Total Patients Enrolled
2 Trials studying Autism Spectrum Disorder
161 Patients Enrolled for Autism Spectrum Disorder
National Institute of Mental Health (NIMH)NIH
2,798 Previous Clinical Trials
2,660,618 Total Patients Enrolled
82 Trials studying Autism Spectrum Disorder
40,102 Patients Enrolled for Autism Spectrum Disorder

Media Library

Autism Spectrum Disorder Research Study Groups: Standard Transition Services + Work Chat, Standard Transition Services
Autism Spectrum Disorder Clinical Trial 2023: Standard Transition Services + Work Chat Highlights & Side Effects. Trial Name: NCT05565482 — N/A
~52 spots leftby Oct 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top